[Pathogenic and Compensatory Mechanisms in Epidermis of Sphingomyelin Synthase 2-Deficient Mice].
Differentiation
Keratinocyte
Proliferation
Skin barrier function
Sphingomyelin
Sphingomyelin synthase
Journal
Skin pharmacology and physiology
ISSN: 1660-5535
Titre abrégé: Skin Pharmacol Physiol
Pays: Switzerland
ID NLM: 101188418
Informations de publication
Date de publication:
2021
2021
Historique:
received:
20
08
2020
accepted:
05
01
2021
pubmed:
30
4
2021
medline:
14
1
2022
entrez:
29
4
2021
Statut:
ppublish
Résumé
Sphingomyelin (SM) is a constituent of cellular membranes, while ceramides (Cer) produced from SM on plasma membranes serve as a lipid mediator that regulates cell proliferation, differentiation, and apoptosis. In the skin, SM also is a precursor of Cer, an important constituent of epidermal permeability barrier. We investigated the role of epidermal SM synthase (SMS)2, an isoform of SMS, which modulates SM and Cer levels on plasma membranes. Although SMS2-knockout (SMS2-KO) mice were not neonatal lethal, an ichthyotic phenotype with epidermal hyperplasia and hyperkeratosis was evident at birth, which persisted until 2 weeks of age. These mice showed abnormal lamellar body morphology and secretion, and abnormal extracellular lamellar membranes in the stratum corneum. These abnormalities were no longer evident by 4 weeks of age in SMS2-KO mice. Our study suggests that (1) exposure to a dry terrestrial environment initiates compensatory responses, thereby normalizing epidermal ichthyotic abnormalities and (2) that a nonlethal gene abnormality can cause an ichthyotic skin phenotype.
Identifiants
pubmed: 33915532
pii: 000515608
doi: 10.1159/000515608
pmc: PMC8410625
mid: NIHMS1682397
doi:
Substances chimiques
Transferases (Other Substituted Phosphate Groups)
EC 2.7.8.-
phosphatidylcholine-ceramide phosphocholine transferase
EC 2.7.8.-
Sgms2 protein, mouse
EC 2.7.8.27
Types de publication
Journal Article
Langues
chi
Sous-ensembles de citation
IM
Pagination
246-252Subventions
Organisme : NIAMS NIH HHS
ID : R01 AR051077
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR061106
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR062025
Pays : United States
Informations de copyright
© 2021 S. Karger AG, Basel.
Références
FEBS Lett. 2006 Oct 9;580(23):5456-66
pubmed: 16962101
J Oleo Sci. 2019 May 1;68(5):427-441
pubmed: 30971644
J Biol Chem. 2011 Aug 12;286(32):28544-55
pubmed: 21669879
Biochem J. 2011 Apr 15;435(2):381-90
pubmed: 21303347
Biochim Biophys Acta. 2014 Mar;1841(3):453-62
pubmed: 24055887
Skin Pharmacol Physiol. 2009;22(4):178-89
pubmed: 19648779
J Biochem. 1989 May;105(5):684-90
pubmed: 2753867
Biochim Biophys Acta. 2014 May;1841(5):692-703
pubmed: 24355909
J Lipid Res. 2000 Dec;41(12):2071-82
pubmed: 11108741
J Invest Dermatol. 2009 Jul;129(7):1824-35
pubmed: 19177139
J Invest Dermatol. 2010 Oct;130(10):2497-9
pubmed: 20520629
J Biol Chem. 1997 Oct 31;272(44):27730-6
pubmed: 9346915
Br J Dermatol. 2005 Mar;152(3):426-34
pubmed: 15787810
PLoS One. 2018 Apr 12;13(4):e0195151
pubmed: 29649284
Exp Dermatol. 2018 Aug;27(8):827-832
pubmed: 29345004
J Invest Dermatol. 2002 Aug;119(2):416-23
pubmed: 12190865
J Lipid Res. 2020 Jun;61(6):884-895
pubmed: 32265320